These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2601830

  • 21. Causative Drugs of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Israel.
    Maggio N, Firer M, Zaid H, Bederovsky Y, Aboukaoud M, Gandelman-Marton R, Noyman I, Ekstein D, Blatt I, Marom E, Schwartzberg E, Israel S, Ingber A, Brautbar C, Eyal S.
    J Clin Pharmacol; 2017 Jul; 57(7):823-829. PubMed ID: 28181259
    [No Abstract] [Full Text] [Related]

  • 22. Case report: psychosis with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    de Rego JA, Goldstein DM.
    Hillside J Clin Psychiatry; 1985 Jul; 7(2):141-8. PubMed ID: 4077031
    [Abstract] [Full Text] [Related]

  • 23. Management of drug-induced toxic epidermal necrolysis.
    Eisen ER, Fish J, Shear NH.
    J Cutan Med Surg; 2000 Apr; 4(2):96-102. PubMed ID: 11179933
    [No Abstract] [Full Text] [Related]

  • 24. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
    Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F.
    N Engl J Med; 1995 Dec 14; 333(24):1600-7. PubMed ID: 7477195
    [Abstract] [Full Text] [Related]

  • 25. Toxic epidermal necrolysis due to antiepileptic therapy in an 8-year-old boy.
    Muhar U, Granditsch G, Diem E.
    Pediatr Dermatol; 1985 Nov 14; 3(1):54-8. PubMed ID: 4070087
    [Abstract] [Full Text] [Related]

  • 26. The association of HLA B*15:02 allele and Stevens-Johnson syndrome/toxic epidermal necrolysis induced by aromatic anticonvulsant drugs in a South Indian population.
    Devi K.
    Int J Dermatol; 2018 Jan 14; 57(1):70-73. PubMed ID: 29076187
    [Abstract] [Full Text] [Related]

  • 27. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N, Bastuji-Garin S, Mockenhaupt M, Roujeau JC, Flahault A, Kelly JP, Martin E, Kaufman DW, Maison P.
    Pediatrics; 2009 Feb 14; 123(2):e297-304. PubMed ID: 19153164
    [Abstract] [Full Text] [Related]

  • 28. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
    Aberer W, Stingl G, Wolff K.
    Hautarzt; 1982 Sep 14; 33(9):484-90. PubMed ID: 7174320
    [Abstract] [Full Text] [Related]

  • 29. Genetic variants associated with phenytoin-related severe cutaneous adverse reactions.
    Chung WH, Chang WC, Lee YS, Wu YY, Yang CH, Ho HC, Chen MJ, Lin JY, Hui RC, Ho JC, Wu WM, Chen TJ, Wu T, Wu YR, Hsih MS, Tu PH, Chang CN, Hsu CN, Wu TL, Choon SE, Hsu CK, Chen DY, Liu CS, Lin CY, Kaniwa N, Saito Y, Takahashi Y, Nakamura R, Azukizawa H, Shi Y, Wang TH, Chuang SS, Tsai SF, Chang CJ, Chang YS, Hung SI, Taiwan Severe Cutaneous Adverse Reaction Consortium, Japan Pharmacogenomics Data Science Consortium.
    JAMA; 2014 Aug 06; 312(5):525-34. PubMed ID: 25096692
    [Abstract] [Full Text] [Related]

  • 30. Toxic epidermal necrolysis of the scalp following anticonvulsant use and cranial irradiation.
    Trent JT, Bowes LE, Romanelli P, Kerdel FA.
    J Cutan Med Surg; 2001 Aug 06; 5(6):475-8. PubMed ID: 11907855
    [Abstract] [Full Text] [Related]

  • 31. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.
    Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC.
    Arch Dermatol; 1993 Jan 06; 129(1):92-6. PubMed ID: 8420497
    [Abstract] [Full Text] [Related]

  • 32. Stevens-Johnson syndrome and toxic epidermal necrolysis in a patient with systemic lupus erythematosus.
    Burge SM, Dawber RP.
    J Am Acad Dermatol; 1985 Oct 06; 13(4):665-6. PubMed ID: 4078055
    [No Abstract] [Full Text] [Related]

  • 33. HLA-B∗ 1502 is associated with carbamazepine induced Stevens-Johnson syndrome in North Indian population.
    Aggarwal R, Sharma M, Modi M, Garg VK, Salaria M.
    Hum Immunol; 2014 Nov 06; 75(11):1120-2. PubMed ID: 25305458
    [Abstract] [Full Text] [Related]

  • 34. [Toxic epidermal necrolysis after treatment with lamotrigine].
    Zachariae CO, Fogh K.
    Ugeskr Laeger; 1998 Nov 09; 160(46):6656-7. PubMed ID: 9825684
    [Abstract] [Full Text] [Related]

  • 35. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR, Blaylock RC, Morris SE, Jung JY.
    J Am Acad Dermatol; 2013 Aug 09; 69(2):221-5. PubMed ID: 23673282
    [Abstract] [Full Text] [Related]

  • 36. Toxic epidermal necrolysis.
    Lacy JA.
    Nutr Clin Pract; 1991 Feb 09; 6(1):18-20. PubMed ID: 1775102
    [Abstract] [Full Text] [Related]

  • 37. Usefulness of case report literature in determining drugs responsible for toxic epidermal necrolysis.
    Stern RS, Chan HL.
    J Am Acad Dermatol; 1989 Aug 09; 21(2 Pt 1):317-22. PubMed ID: 2671067
    [Abstract] [Full Text] [Related]

  • 38. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S, Das A, Ghosh A, Sil A, Gharami RC, Bandyopadhyay D, Das NK.
    Indian J Dermatol Venereol Leprol; 2017 Aug 09; 83(3):312-316. PubMed ID: 28366923
    [Abstract] [Full Text] [Related]

  • 39. Fatal Stevens-Johnson syndrome/toxic epidermal necrolysis induced by allopurinol-rituximab-bendamustine therapy.
    Fallon MJ, Heck JN.
    J Oncol Pharm Pract; 2015 Oct 09; 21(5):388-92. PubMed ID: 25005569
    [Abstract] [Full Text] [Related]

  • 40. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study.
    Lin MS, Dai YS, Pwu RF, Chen YH, Chang NC.
    Intern Med J; 2005 Mar 09; 35(3):188-90. PubMed ID: 15737140
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.